Combined treatment of GCV with lapatinib only partially suppressed tumor growth in mice injected with SORE6-mcherry-expressing Neu cells, but largely abolished and even caused regression of tumor growth in mice injected with SORE6-hTK-expressing cells (Figure 6D). This evidence concerns the gene ERBB2 and neoplasm.